Medifast stock rises as revenue tops estimates

Published on 09/03/2026 at 21:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medifast stock gained after a stronger August 3 earnings update and a September 2 close at USD 12.66. The latest report showed USD 76.38 million in revenue and EPS of negative USD 0.28.

Medifast (US58470S1024) stock closed at USD 12.66 on September 2, 2026, up 4.73 percent, with market capitalization at USD 141.57 million and volume at 224,442 shares. The latest earnings update on August 3, 2026, showed revenue of USD 76.38 million and EPS of negative USD 0.28, both ahead of expectations.

Earnings still set the tone

According to MarketBeat, Medifast finished September 2 at USD 12.66, while the 52-week range ran from USD 9.22 to USD 14.67. That leaves the shares inside the upper half of the range and above the USD 12.00 consensus target quoted on the same page.

The August 3 report also mattered because revenue of USD 76.38 million beat the USD 72.70 million estimate by USD 3.68 million, while EPS beat consensus by USD 0.37. For investors, that gap is more relevant than the day-to-day price move.

Guidance and valuation

MarketBeat puts the price target at USD 12.00 and the consensus rating at Reduce, while also showing a negative trailing P/E and a market value of USD 141.57 million. The stock therefore trades close to the target, but still with a valuation picture shaped by losses rather than earnings power.

Forbes lists revenue (ttm) at USD 316.93 million, EBITDA at negative USD 5.66 million and net margin at negative 8.08 percent. Those figures frame the August quarter as an earnings beat, not a full operating turnaround.

Go deeper

Medifast shares, earnings and valuation

The latest figures tie the stock to the August 3 earnings beat and the September 2 market close.

OPTAVIA drives the model

The company sells weight-management products and coaching through OPTAVIA, its direct-to-consumer brand. MarketBeat describes Medifast as a health and wellness company that combines meal replacements, snacks, supplements and coaching programs.

Stock close on September 2

Medifast stock ended September 2, 2026, at USD 12.66 on the NYSE, with the intraday range at USD 12.17 to USD 13.04. The combination of a 4.73 percent daily gain, a USD 141.57 million market value and an August earnings beat keeps the shares on the radar.